Us Bancorp \De\ Surface Oncology, Inc. Transaction History

Us Bancorp \De\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$5.16 - $7.98 $1,465 - $2,266	-284 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$6.45 - $9.09 $2,193 - $3,090	-340 Reduced 54.49%	284 $2,000
Q1 2021 Apr 28, 2021	SELL	$7.25 - $13.82 $1,261 - $2,404	-174 Reduced 21.8%	624 $5,000
Q4 2020 Feb 04, 2021	BUY	$6.87 - $10.48 $5,482 - $8,363	798 New	798 $7,000
Q2 2019 Aug 13, 2019	SELL	$2.75 - $4.89 $1,375 - $2,445	-500 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$4.11 - $5.88 $2,055 - $2,940	500 New	500 $2,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.